Document is current

Article History

Received: 3 February 2021

Accepted: 10 March 2021

First Online: 26 March 2021

Declarations

:

: The patients reported here participated in a clinical trial that was registered on (NCT02721732). The trial protocol was approved by the US Food and Drug Administration and the institutional review board at MDACC. The study was conducted in accordance with the Declaration of Helsinki and the International Conference on Harmonization Good Clinical Practice guidelines. All study participants provided written informed consent before enrollment.

: The patients reported here participated in a clinical trial that was registered on (NCT02721732). The trial protocol was approved by the US Food and Drug Administration and the institutional review board at MDACC. All procedures performed in studies of human subjects were in accordance with the ethical standards of the institutional review board and with the Declaration of Helsinki and the International Conference on Harmonization Good Clinical Practice guidelines.

: All study participants provided written informed consent before enrollment.

: Individual patient consent for publication is not necessary because this case series does not include identifying data.

: Andrew W. Hahn, Jad Chahoud, Jennifer Wang, and Bettzy A. Stephen have no conflicts to disclose.Matthew T. Campbell reports consulting/honorarium: Eisai, Exelixis, EMD Serono, Pfizer, AstraZeneca, Seattle Genetics, research grant funding: Exelixis, Pfizer, EMD Serono, ApricityHealth, Janssen.Curtis A. Pettaway reports consulting to Wolters Kluwer for “UpToDate series.”Aung Naing reports consulting to CytomX Therapeutics, Novartis, Kymab, Genome, OncoSec KEYNOTE-695, and STCube Pharmaceuticals. He reports travel and accommodation expenses from ARMO BioSciences. He reports research funding to his institution from NCI, EMD Serono, MedImmune, Healios Onc. Nutrition, Atterocor, Amplimmune, ARMO BioSciences, Eli Lilly, Karyopharm Therapeutics, Incyte, Novartis, Regeneron, Merck, Bristol Myers Squibb, Pfizer, CytomX Therapeutics, Neon Therapeutics, Calithera Biosciences, TopAlliance Biosciences, Kymab, PsiOxus, Arcus Biosciences, NeoImmuneTech, ImmuneOncia, and Surface Oncology. Spouse reports research funding to her institution from Immune Deficiency Foundation Jeffery Modell Foundation and chao physician-scientist, and Baxalta; and is on the advisory board of Takeda, CSL, Behring, Horizon, and Pharming.